P. Schoenfeld Asset Management (PSAM)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-176,500	Closed	-$23.3M	–	44
2025 Q1	$23.3M	Buy	+176,500	New	+$22M	6.53%	6

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM)'s ITCI Position: Q2 2025 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 176,500 shares — an estimated $23.3M sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $23.3M in Q1 2025. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

P. Schoenfeld Asset Management (PSAM) reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
P. Schoenfeld Asset Management (PSAM) sold 176,500 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $23.3M.
P. Schoenfeld Asset Management (PSAM) first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
P. Schoenfeld Asset Management (PSAM)'s Intra-Cellular Therapies Inc. position peaked at $23.3M in Q1 2025.
3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q2 2025, filed 14 Aug 2025.